SWISS major Novartis AG has moved the Supreme Court challenging Intellectual Property Appellate Board (IPAB) decision to reject its patent application of blood cancer drug Glivec in India. The case is expected to be heard on Monday.

A study done by the Coalition for Healthy India (CHI), an initiative of the US India Business Council (USIBC), brings the subject of pharmaceutical innovation and drug patents into public discourse.

Although the first batch of swine flu vaccines are supposed to be ready and licenced by October, most healthcare workers do not want to be the first to be vaccinated. The reason behind the reluctance is the 1976 swine flu fiasco in the US when the vaccine supposedly killed 25 people while the virus only claimed one life.

THE government plans to centralise the purchase of medicines for its dispensaries and healthcare centres across the country, a health ministry official said. The step is being taken after social activists have alleged that a decentralise procurement system is breeding corruption, the official, who did not want to be named, said.

DRL, Cipla Among Cos Found Involved In Overcharging By Drug Price Regulator

Eighty five per cent of the nation

The government will soon appoint a Commissioner of Food Safety and a Food Safety Appellate Tribunal to check adulteration of food items and medicines. This was stated by Health Minister Rajiv Bindal while replying to the issue of adulteration in food items and medicines, raised by Kuldeep Pathania of the Congress under Rule 63 in the Assembly today.

Delhi HC Ruling Big Victory For Indian Drugmakers

IN A major win for Indian pharma companies, the Delhi High Court (HC) on Tuesday dismissed German drug major Bayer Healthcare

Aug. 18: After off-shoring and outsourcing, the US

INDIA may soon get its own vaccine for swine flu or the H1N1 virus that has killed hundreds across the globe this year. Three domestic biotech firms